Morsy, Y.; Brillant, N.; Franc, Y.; Scharl, M.; Wawrzyniak, M.; on behalf of the Swiss IBD Cohort Study Group.
Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease. Cells 2021, 10, 3589.
https://doi.org/10.3390/cells10123589
AMA Style
Morsy Y, Brillant N, Franc Y, Scharl M, Wawrzyniak M, on behalf of the Swiss IBD Cohort Study Group.
Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease. Cells. 2021; 10(12):3589.
https://doi.org/10.3390/cells10123589
Chicago/Turabian Style
Morsy, Yasser, Nathalie Brillant, Yannick Franc, Michael Scharl, Marcin Wawrzyniak, and on behalf of the Swiss IBD Cohort Study Group.
2021. "Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease" Cells 10, no. 12: 3589.
https://doi.org/10.3390/cells10123589
APA Style
Morsy, Y., Brillant, N., Franc, Y., Scharl, M., Wawrzyniak, M., & on behalf of the Swiss IBD Cohort Study Group.
(2021). Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease. Cells, 10(12), 3589.
https://doi.org/10.3390/cells10123589